Form 4: Corvel Corp Chairman Sells Shares in Multiple Transactions
SEC Form 4 Filing
Corvel Corp's Chairman of the Board, V. Gordon Clemons, sold 8,000 shares of common stock in two transactions, with the shares being held indirectly through a spouse's living trust.
Summary
- V. Gordon Clemons, Chairman of the Board at Corvel Corp, sold a total of 8,000 shares of common stock.
- The sales occurred in two separate transactions on November 29, 2024, and December 2, 2024.
- 2,000 shares were sold on November 29 at a price of $367.50 per share.
- 6,000 shares were sold on December 2 at a price of $365.0511 per share.
- The shares were held indirectly through the Marie Eve Clemons Living Trust.
- Following these transactions, Mr. Clemons indirectly holds 241,584 shares through the trust, and directly holds 834,492 shares.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock sales by an insider. It doesn't indicate positive or negative sentiment about the company's performance.
Management Comments
- The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes.
Industry Context
This is a standard SEC Form 4 filing, which is common for corporate insiders who trade their company's stock. These transactions are closely watched by investors for insights into management's view of the company's prospects.
Comparison to Industry Standards
- Insider trading activity is a common occurrence in publicly traded companies, and the reporting requirements are standardized across the industry.
- The volume of shares sold by Mr. Clemons is not unusual for a corporate officer, and the transactions are within the normal range of insider trading activity.
- Comparable companies would also have similar filings when their executives trade shares.
Stakeholder Impact
- The stock sales by a high-ranking executive could be perceived negatively by some shareholders, potentially leading to a slight decrease in share price.
Key Dates
| Date | Description |
|---|---|
| 11/29/2024 | 2,000 shares of common stock were sold at $367.50 per share. |
| 12/02/2024 | 6,000 shares of common stock were sold at $365.0511 per share. |
| 12/03/2024 | Date of signature for the SEC Form 4 filing. |
Keywords
Corvel Corp, CRVL, V. Gordon Clemons, share sale, insider trading, stock transaction, beneficial ownership, Marie Eve Clemons Living Trust
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.